OpenEvidence, which Forbes profiled in July, has been signing up users fast. Its ultimate goal: To not just help doctors find existing medical research, but to create medical superintelligence.
ByAmy Feldman,
Forbes Staff
andRashi Shrivastava,
Forbes Staff.
O
Daniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence, is now worth $7.6 billion as his AI search tool surges in…
OpenEvidence, based in Massachusetts, has topped a $12 billion valuation in a funding round led by Thrive and DST.
OpenEvidence chief Daniel Nadler says he envisions changing the company’s ad-supported model, which has kept it free for medical…
OpenEvidence built out a voice AI feature as part of its popular medical search engine that gives physicians a hands-free way to…
OpenEvidence CTO Zachary Ziegler said, at the STAT Breakthrough Summit West, that the company is looking beyond physician users.
Nineteen new AI billionaires amassed $59.3 billion as startups like Mercor, Harvey and OpenEvidence turn AI into profit.
